Celgene Corp (NASDAQ:CELG)

115.28
Delayed Data
As of Mar 31
 -4.74 / -3.95%
Today’s Change
66.85
Today|||52-Week Range
129.06
+3.06%
Year-to-Date

Today’s Trading

Previous close120.02
Today’s open118.88
Day’s range-- - --
Volume11,331,811
Average volume (3 months)5,551,011
Market cap$96.1B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+41.84%
Earnings growth (this year)+29.76%
Earnings growth (next 5 years)+23.49%
Revenue growth (last year)+17.89%
P/E ratio48.2
Price/Sales11.75
Price/Book14.72

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.30+0.52%
AZNAstraZeneca-1.51-2.16%
BMYBristol-Myers Squibb-1.26-1.92%
LLYEli Lilly and Co-1.22-1.65%
Data as of 03/31/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$1.06
Annual revenue (last year)$7.6B
Annual profit (last year)$2.0B
Net profit margin26.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account